clinical trial · NCT06321601
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
VasculitisAvacopan
brief summary
The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.
started
Oct 22, 2024
primary completion
Sep 26, 2028
completion
Sep 26, 2028
last updated
May 14, 2026
official title
A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol